EuBiologics Secures KRW30 Billion Cholera Vaccine UNICEF Contract
South Korean biopharmaceutical company EuBiologics (KOSDAQ:206650) secured a contract from UNICEF for the supply of oral cholera vaccines Euvichol/Euvichol-S, according to a Tuesday filing with the Korea Exchange.The contract, valued at 29.8 billion won, is valid until Aug. 14.Shares of EuBiologics fell over 6% in recent trade.